OC-01 (Varenicline) Nasal Spray and Dry Eye Signs and Symptoms in Daily Disposable Contact Lens Wearers
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study is a single center, prospective, randomized, controlled, double-masked, two-arm
investigator-initiated study to investigate the efficacy of OC-01 (varenicline) nasal spray
on the signs and symptoms of dry eye disease in daily soft contact lens wearers.